How have GSAC shares performed in 2024?

GelStat's stock was trading at $0.0003 at the beginning of the year. Since then, GSAC shares have increased by 50.0% and is now trading at $0.0005. View the best growth stocks for 2024 here .

How do I buy shares of GelStat?

Shares of GSAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:GSAC

GelStat (GSAC) Stock Price, News & Analysis

→ The system that called 2023’s top 7 stocks is at it again… (From WealthPress) (Ad)

Free GSAC Stock Alerts

$0.0005

0.00 (0.00%)

(As of 04/18/2024 ET)

Compare

Today's Range: $0.0005
▼
$0.0005
50-Day Range: N/A
52-Week Range: $0.0001
▼
$0.0017

Volume: N/A
Average Volume: 2.47 million shs
Market Capitalization: $278,091.00

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Financials SEC Filings Short Interest

Get GelStat alerts:

Ad DTI

This company has increased its dividend every year for 54 years

There are three basic steps to building the Ultimate Dividend Portfolio. Step #1 is to Get The High Yields! So an index fund like the SPY, paying only 1.5% a year, isn’t going to cut it. But a company like Altria Group (MO) will.

Click here to get them (for Free).

About GelStat Stock (OTCMKTS:GSAC)

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialty distributors, and catalog merchandisers both directly and through external sales brokers. GelStat Corporation was founded in 2002 and is headquartered in Palm City, Florida.

GSAC Stock Price History

30 days | 90 days | 365 days | Advanced Chart

GSAC Stock News Headlines

September 6, 2022 | marketwatch.com

Functional Chewing Gum Market 2022 | with COVID-19 Pandemic Analysis & Future Growth Analysis by prime Key Players and Regional Forecast 2026

August 26, 2022 | marketwatch.com

Functional Chewing Gum Market Is PoIsed to Reflect 5.3%% CAGR by 2027 | 111 Report Pages

April 19, 2024 | WealthPress (Ad)

The system that called 2023’s top 7 stocks is at it again…

Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.

August 15, 2022 | reuters.com

GSAC.PK - Gelstat Corp | Stock Price & Latest News | Reuters

June 2, 2022 | finance.yahoo.com

GelStat Announces $5 Million Public Offering Under Regulation A+

June 2, 2022 | finance.yahoo.com

GelStat Provides Corporate Update on Capital Restructuring

See More Headlines

Receive GSAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GelStat and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/19/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: OTCMKTS:GSAC
CUSIP: N/A
CIK: 890725
Web: www.gelstat.com
Phone: (772) 212-1368
Fax: 888-512-3766
Employees: 2
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 617,980,000
Free Float: 491,294,000
Market Cap: $278,091.00
Optionable: Not Optionable
Beta: 2.25

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

Mr. Javier G. Acosta
CEO & Director
Mr. Charles F. Tarzian (Age 67)
Chief Marketing Advisor
Dr. Roger K. Cady M.D.
Chief Medical Advisor

Key Competitors

View All Competitors

GSAC Stock Analysis - Frequently Asked Questions

How have GSAC shares performed in 2024?: GelStat's stock was trading at $0.0003 at the beginning of the year. Since then, GSAC shares have increased by 50.0% and is now trading at $0.0005.
View the best growth stocks for 2024 here.
How do I buy shares of GelStat?: Shares of GSAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:GSAC) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial